United Kingdom
# |
Name |
Revenue |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 45.81 B
|
Dec. 31, 2023 | USD 129.77 | -1.69% |
|
United Kingdom |
|
2 |
USD 2.63 B
|
Dec. 31, 2023 | USD 5.03 | -1.57% |
|
United Kingdom |
|
3 |
USD 846.50 M
|
June 30, 2024 | USD 17.38 | -3.70% |
|
United Kingdom |
|
4 |
USD 249.43 M
|
Dec. 31, 2023 | USD 28.56 | -4.90% |
|
United Kingdom |
|
5 |
USD 215.87 M
|
Dec. 31, 2023 | USD 1.73 | -0.82% |
|
United Kingdom |
|
6 |
USD 144.21 M
|
Dec. 31, 2023 | USD 5.68 | 0.09% |
|
United Kingdom |
|
7 |
USD 124.80 M
|
March 31, 2024 | USD 10.94 | 1.86% |
|
United Kingdom |
|
8 |
USD 120.85 M
|
Sept. 30, 2024 | USD 0.36 | 3.24% |
|
United Kingdom |
|
9 |
USD 113.92 M
|
Dec. 31, 2023 | USD 4.79 | -4.31% |
|
United Kingdom |
|
10 |
USD 112.83 M
|
March 31, 2024 | USD 0.78 | -0.69% |
|
United Kingdom |
|
11 |
USD 82.25 M
|
April 30, 2024 | USD 0.64 | 0.47% |
|
United Kingdom |
|
12 |
USD 69.87 M
|
June 30, 2024 | USD 0.09 | 2.54% |
|
United Kingdom |
|
13 |
USD 66.94 M
|
Dec. 31, 2023 | USD 0.31 | 0.09% |
|
United Kingdom |
|
14 |
USD 46.82 M
|
Dec. 30, 2023 | USD 72.03 | -1.91% |
|
United Kingdom |
|
15 |
USD 39.19 M
|
Dec. 31, 2023 | USD 0.23 | 1.46% |
|
United Kingdom |
|
16 |
USD 32.29 M
|
Dec. 31, 2023 | USD 5.61 | -4.92% |
|
United Kingdom |
|
17 |
USD 29.58 M
|
Dec. 31, 2023 | USD 0.62 | -2.80% |
|
United Kingdom |
|
18 |
USD 29.49 M
|
Dec. 31, 2023 | USD 0.70 | -2.31% |
|
United Kingdom |
|
19 |
USD 26.98 M
|
Dec. 31, 2023 | USD 14.81 | -2.31% |
|
United Kingdom |
|
20 |
USD 17.22 M
|
June 30, 2024 | USD 39.06 | 2.49% |
|
United Kingdom |
|
21 |
USD 17.20 M
|
Dec. 31, 2023 | USD 0.49 | 0.09% |
|
United Kingdom |
|
22 |
USD 11.73 M
|
Nov. 30, 2023 | USD 0.03 | 0.09% |
|
United Kingdom |
|
23 |
USD 10.00 M
|
Dec. 31, 2023 | USD 3.06 | -8.38% |
|
United Kingdom |
|
24 |
USD 8.88 M
|
Dec. 31, 2023 | USD 0.05 | 0.09% |
|
United Kingdom |
|
25 |
USD 7.77 M
|
June 30, 2024 | USD 0.10 | 0.09% |
|
United Kingdom |
|
26 |
USD 7.71 M
|
Sept. 30, 2024 | USD 0.14 | 0.09% |
|
United Kingdom |
|
27 |
USD 6.40 M
|
Dec. 31, 2023 | USD 0.05 | 1.50% |
|
United Kingdom |
|
28 |
USD 5.82 M
|
Dec. 31, 2023 | USD 0.71 | 0.09% |
|
United Kingdom |
|
29 |
USD 2.78 M
|
Dec. 31, 2023 | USD 0.14 | 0.09% |
|
United Kingdom |
|
30 |
USD 2.76 M
|
March 31, 2024 | USD 0.15 | 0.09% |
|
United Kingdom |
|
31 |
USD 2.75 M
|
Dec. 31, 2023 | USD 0.04 | 0.09% |
|
United Kingdom |
|
32 |
USD 1.70 M
|
Dec. 31, 2023 | USD 2.21 | -3.91% |
|
United Kingdom |
|
33 |
USD 1.53 M
|
June 30, 2024 | USD 0.19 | -3.04% |
|
United Kingdom |
|
34 |
USD 1.51 M
|
May 31, 2024 | USD 0.24 | -4.72% |
|
United Kingdom |
|
35 |
USD 1.46 M
|
Aug. 31, 2023 | USD 0.16 | -0.68% |
|
United Kingdom |
|
36 |
USD 1.43 M
|
March 31, 2024 | USD 0.11 | -6.40% |
|
United Kingdom |
|
37 |
USD 1.01 M
|
Dec. 31, 2023 | USD 0.05 | -16.59% |
|
United Kingdom |
|
38 |
USD 819.38 K
|
Dec. 31, 2023 | USD 0.21 | 0.09% |
|
United Kingdom |
|
39 |
USD 802.00 K
|
Dec. 31, 2023 | USD 0.95 | 0.80% |
|
United Kingdom |
|
40 |
USD 735.26 K
|
Dec. 31, 2023 | USD 0.13 | -2.30% |
|
United Kingdom |
|
41 |
USD 643.80 K
|
Dec. 31, 2023 | USD 15.26 | 0.09% |
|
United Kingdom |
|
42 |
USD 634.12 K
|
June 30, 2024 | USD 0.03 | -4.36% |
|
United Kingdom |
|
43 |
USD 622.30 K
|
Sept. 30, 2023 | USD 0.01 | -33.27% |
|
United Kingdom |
|
44 |
USD 484.76 K
|
Dec. 31, 2023 | USD 4.18 | -2.79% |
|
United Kingdom |
|
45 |
USD 453.12 K
|
June 30, 2024 | USD 0.31 | 0.09% |
|
United Kingdom |
|
46 |
USD 254.47 K
|
Dec. 31, 2023 | USD 0.04 | -9.47% |
|
United Kingdom |
|
47 |
USD 156.42 K
|
March 31, 2024 | USD 2.29 | -3.78% |
|
United Kingdom |
|
48 |
USD 95.42 K
|
Dec. 31, 2023 | USD 0.20 | 0.09% |
|
United Kingdom |
|
49 |
USD 0.00
|
June 30, 2024 | USD 0.27 | 2.36% |
|
United Kingdom |
|
50 |
USD 0.00
|
Dec. 31, 2023 | USD 1.04 | 1.96% |
|
United Kingdom |
The Biotechnology company in United Kingdom with the highest Revenue is AstraZeneca PLC (LSE: AZN.L) at USD 45.81 B.
The Biotechnology company in United Kingdom with the lowest Revenue is Verona Pharma plc (NasdaqGM: VRNA) at USD 0.00.
The top 10 Biotechnology companies in United Kingdom by Revenue are AstraZeneca PLC, Clarivate Plc, Genus plc, Immunocore Holdings plc, Oxford Nanopore Technologies plc, Science Group plc, Roivant Sciences Ltd., Benchmark Holdings plc, Oxford Biomedica plc and ECO Animal Health Group plc.
The bottom 10 Biotechnology companies in United Kingdom by Revenue are Verona Pharma plc, Synairgen plc, Scancell Holdings plc, OKYO Pharma Limited, Genflow Biosciences plc, Hemogenyx Pharmaceuticals Plc, ImmuPharma plc, Poolbeg Pharma PLC, NuCana plc and Sareum Holdings plc.